Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

A mother's diet at conception can cause lasting genetic changes in her child.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Childhood obesity is rising globally due to various factors, and early prevention and healthy lifestyle changes are crucial.

Women with PCOS often have more belly fat and higher insulin levels, but belly fat isn't the only cause of their insulin resistance.

Polymeric nanoparticles show promise for treating skin diseases.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Hair follicles help absorb and store topical compounds, aiding targeted drug delivery.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Stress stops hair growth in mice by causing early hair growth phase end and harmful inflammation through a specific nerve-related pathway.

Hair follicles significantly increase the speed and amount of caffeine absorbed through the skin.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Wnt signaling controls whether hair follicle stem cells stay inactive or regenerate hair.

The document concludes that the exact way alcohol causes harm to fetal development is unknown, but it significantly affects nutrient transport to the fetus and a safe level of alcohol during pregnancy is not determined.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Caffeine in cosmetics may reduce cellulite, protect skin, and stimulate hair growth, but more research is needed on its use and effects.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Hair follicles may soon be used more for targeted and systemic drug delivery.

Microneedles improve drug delivery in various body parts, are safe and painless, and show promise in cosmetology, vaccination, insulin delivery, and other medical applications.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.